[Late coronary stent thrombosis and clopidogrel]

Area of Science:

• Cardiology
• Interventional Cardiology

Background:

• Late coronary stent thrombosis is a significant clinical issue.
• Understanding its incidence and definition is crucial for patient outcomes.

Purpose of the Study:

• To evaluate the long-term safety of bare metal stents (BMS) and drug-eluting stents (DES).
• To define optimal treatment durations for thienopyridine therapy post-percutaneous coronary intervention (PCI).

Main Methods:

• Review of observational and randomized studies.
• Analysis of safety profiles associated with BMS and DES implantation.
• Assessment of thienopyridine treatment duration based on stent type.

Main Results:

• Bare metal stent implantation is associated with long-term safety after one month of treatment.
• Drug-eluting stent implantation requires a 12-month clopidogrel administration period for optimal safety.
• Incidence and temporal definition of late stent thrombosis are discussed.

Conclusions:

• Treatment duration for thienopyridin therapy varies significantly between BMS and DES.
• Future advancements in DES technology and long-term clopidogrel data may influence current treatment guidelines.